90
Views
42
CrossRef citations to date
0
Altmetric
Original Article

Systemic Poly chemotherapy in the Treatment of Primary Cutaneous Lymphomas: a Clinical Follow-Up Study of 81 Patients Treated with COP or CHOP

, , , &
Pages 583-588 | Accepted 25 Feb 1998, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Emmanuel Ribereau-Gayon, Marie Donzel, Felix Pham, Nicolas Romain-Scelle, Marie Perier-Muzet, Brigitte Balme, Alexandra Traverse-Glehen, Hervé Ghesquières & Stéphane Dalle. (2023) Brentuximab-vedotin in combination with cyclophosphamide, doxorubicin, prednisolone for the treatment of aggressive CD30-positive cutaneous T-cell lymphomas. Leukemia & Lymphoma 64:8, pages 1424-1432.
Read now
Reinhard Dummer. (2005) Emerging drugs in cutaneous T-cell lymphomas. Expert Opinion on Emerging Drugs 10:2, pages 381-392.
Read now
DA Pichardo, C Querfeld, J Guitart, TM Kuzel & ST Rosen. (2004) Cutaneous T-Cell Lymphoma: A Paradigm for Biological Therapies. Leukemia & Lymphoma 45:9, pages 1755-1765.
Read now
Narin Apisarnthanarax & Madeleine Duvic. (2001) Therapy options in cutaneous T-cell lymphoma. Expert Review of Anticancer Therapy 1:3, pages 403-420.
Read now

Articles from other publishers (38)

Christiane Querfeld, Steven T. Rosen & Madeleine Duvic. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1948 1964.e5 .
L. Specht & L. Skov. (2019) Cutaneous Lymphomas. Clinical Oncology 31:11, pages 797-807.
Crossref
Lucie Heinzerling, Anke Hartmann & Martina HundLucie Heinzerling, Anke Hartmann & Martina Hund. 2019. Medikamentöse Tumortherapie in der Dermato-Onkologie. Medikamentöse Tumortherapie in der Dermato-Onkologie 135 190 .
H. Miles Prince & Christiane Querfeld. (2018) Integrating novel systemic therapies for the treatment of mycosis fungoides and Sézary syndrome. Best Practice & Research Clinical Haematology 31:3, pages 322-335.
Crossref
Catherine G. Chung & Brian Poligone. (2015) Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma. Dermatologic Clinics 33:4, pages 787-805.
Crossref
Daniel Humme, Alexander Nast, Ricardo Erdmann, Staffan Vandersee & Marc Beyer. (2014) Systematic review of combination therapies for mycosis fungoides. Cancer Treatment Reviews 40:8, pages 927-933.
Crossref
Alberto Fabbri, Emanuele Cencini, Renato Alterini, Pietro Rubegni, Luigi Rigacci, Chiara Delfino, Benedetta Puccini, Michele Fimiani, Alberto Bosi, Monica Bocchia & Nicola Pimpinelli. (2014) Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas. European Journal of Haematology 93:2, pages 129-136.
Crossref
Christiane Querfeld & Steven T. Rosen. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2060 2075.e5 .
Lucie Heinzerling, Anke Hartmann, Martina Hund & Gerold SchulerLucie Heinzerling, Anke Hartmann, Martina Hund & Gerold Schuler. 2014. Medikamentöse Tumortherapie in der Dermato-Onkologie. Medikamentöse Tumortherapie in der Dermato-Onkologie 99 142 .
Chalid Assaf, Jürgen C. Becker, Marc Beyer, Antonio Cozzio, Edgar Dippel, Claus-Detlev Klemke, Peter Kurschat, Michael Weichenthal & Rudolf Stadler. (2013) Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin - Consensus of the lymphoma group of the Working Group Dermatologic Oncology. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11:4, pages 338-347.
Crossref
Reinhard DummerPietro QuaglinoJürgen C. BeckerBaktiar HasanMatthias KarraschSean WhittakerStephen MorrisMichael WeichenthalRudolf StadlerMartine BagotAntonio CozzioMaria G. BernengoRobert Knobler. (2012) Prospective International Multicenter Phase II Trial of Intravenous Pegylated Liposomal Doxorubicin Monochemotherapy in Patients With Stage IIB, IVA, or IVB Advanced Mycosis Fungoides: Final Results From EORTC 21012. Journal of Clinical Oncology 30:33, pages 4091-4097.
Crossref
Benedetta Belloni, Naomi Johansen, L. Frank Glass & Reinhard Dummer. (2012) Recent Advances in the Management of Cutaneous Lymphomas. Seminars in Oncology 39:2, pages 150-162.
Crossref
Tara Bloom, Timothy M. Kuzel, Christiane Querfeld, Joan Guitart & Steven T. Rosen. (2012) Cutaneous T-Cell Lymphomas: A Review of New Discoveries and Treatments. Current Treatment Options in Oncology 13:1, pages 102-121.
Crossref
Christiane Querfeld & Steven T. Rosen. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 432 448 .
Maria Teresa Fierro, Federica Marenco, Mauro Novelli, Paolo Fava, Pietro Quaglino & Maria Grazia Bernengo. (2010) Long-Term Evolution of an Untreated Primary Cutaneous Follicle Center Lymphoma of the Scalp. The American Journal of Dermatopathology 32:1, pages 91-94.
Crossref
Stefano Pulini, Serena Rupoli, Gaia Goteri, Nicola Pimpinelli, Renato Alterini, Alberta Bettacchi, Simonetta Mulattieri, Paola Picardi, Angela Tassetti, Anna Rita Scortechini, Giuseppe Fioritoni & Pietro Leoni. (2009) Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. European Journal of Haematology 82:3, pages 184-193.
Crossref
Nancy J. Senff, Evert M. NoordijkYoun H. Kim, Martine BagotEmilio BertiLorenzo CerroniReinhard DummerMadeleine DuvicRichard T. HoppeNicola PimpinelliSteven T. Rosen, Maarten H. Vermeer, Sean Whittaker & Rein Willemze. (2008) European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 112:5, pages 1600-1609.
Crossref
Filiz Vural, Guray Saydam, Seckin Cagirgan, Banu Ertekin, Mine Hekimgil, Idil Unal, Saliha Soydan & Murat Tombuloglu. (2008) Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature. International Journal of Dermatology 47:7, pages 675-680.
Crossref
Thomas M. Habermann & Mark R. Pittelkow. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2405 2424 .
R. Dummer, C. Assaf, M. Bagot, R. Gniadecki, A. Hauschild, R. Knobler, A. Ranki, R. Stadler & S. Whittaker. (2007) Maintenance therapy in cutaneous T-cell lymphoma: Who, when, what?. European Journal of Cancer 43:16, pages 2321-2329.
Crossref
C. Bachmeyer, V. Orlandini & S. Aractingi. (2006) Topical mechlorethamine and clobetasol in multifocal primary cutaneous marginal zone-B cell lymphoma. British Journal of Dermatology 154:6, pages 1207-1209.
Crossref
Brigitte Dreno. (2006) Standard and new treatments in cutaneous B-cell lymphomas. Journal of Cutaneous Pathology 33:S1, pages 47-51.
Crossref
O. Dereure. (2005) Traitements systémiques des lymphomes cutanés T épidermotropes (hors interféron et photophérèse). Annales de Dermatologie et de Vénéréologie 132, pages 31-36.
Crossref
S. Gellrich, J.M. Muche, A. Wilks, K.C. Jasch, C. Voit, T. Fischer, H. Audring & W. Sterry. (2005) Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas - an applicational observation. British Journal of Dermatology 153:1, pages 167-173.
Crossref
A. Sah, S.L. Barrans, L.A. Parapia, A.S. Jack & R.G. Owen. (2004) Cutaneous B-cell lymphoma: Pathological spectrum and clinical outcome in 51 consecutive patients. American Journal of Hematology 75:4, pages 195-199.
Crossref
P. Quaglino, M.T. Fierro, G.L. Rossotto, P. Savoia & M.G. Bernengo. (2004) Treatment of advanced mycosis fungoides/Sezary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy. British Journal of Dermatology 150:2, pages 327-336.
Crossref
Uwe Wollina, Reinhard Dummer, Norbert H. Brockmeyer, Helga Konrad, J.‐O. Busch, Martin Kaatz, Burkhard Knopf, Hans‐Jürgen Koch & Axel Hauschild. (2003) Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma. Cancer 98:5, pages 993-1001.
Crossref
Maria T Fierro, Paola Savoia, Pietro Quaglino, Mauro Novelli, Manuela Barberis & Maria G Bernengo. (2003) Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases. Journal of the American Academy of Dermatology 49:2, pages 281-287.
Crossref
Hans Theodor Eich, Dorothee Eich, Oliver Micke, Hartmut Sttzer, Claus Casper, Thomas Krieg & Rolf-Peter Mller. (2003) Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma. International Journal of Radiation Oncology*Biology*Physics 55:4, pages 899-906.
Crossref
Narin Apisarnthanarax, Rakshandra Talpur & Madeleine Duvic. (2002) Treatment of Cutaneous T Cell Lymphoma. American Journal of Clinical Dermatology 3:3, pages 193-215.
Crossref
Helen Y Kim-James & Michael P Heffernan. (2001) The diagnosis, evaluation, and treatment of cutaneous T-cell lymphoma. Current Problems in Dermatology 13:6, pages 301-340.
Crossref
Athanassios Argiris, Peter Heald, Timothy Kuzel, Francine M. Foss, Susan DiStasio, Dennis L. Cooper, Susan Arbuck & John R. Murren. (2001) Phase II Trial of 9-Aminocamptothecin as a 72-h Infusion in Cutaneous T-Cell Lymphoma. Investigational New Drugs 19:4, pages 321-326.
Crossref
Elsa Vasquez‐del‐Mercado, Sonia Toussaint, Fernando De La Barreda & Carlos Ortiz‐Hidalgo. (2008) Large B‐cell lymphoma of the leg. International Journal of Dermatology 40:10, pages 648-647.
Crossref
Elsa Vasquez-del-Mercado, Sonia Toussaint, Fernando de la Barreda & Carlos Ortiz-Hidalgo. (2001) Large B-cell lymphoma of the leg. International Journal of Dermatology 40:10, pages 648-647.
Crossref
Siu-Fun Wong. (2016) Oral Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma. Annals of Pharmacotherapy 35:9, pages 1056-1065.
Crossref
J.J. Scarisbrick, F.J. Child, A. Clift, R. Sabroe, S.J. Whittaker, M. Spittle & R. Russell-Jones. (2001) A trial of fludarabine and cyclophosphamide combination chemotherapy in the treatment of advanced refractory primary cutaneous T-cell lymphoma. British Journal of Dermatology 144:5, pages 1010-1015.
Crossref
Uwe Wollina, Annette Looks, Jochen Meyer, Burkhard Knopf, Hans-Jrgen Koch, Kristin Liebold & Uta-Christina Hipler. (2001) Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: A prospective controlled trial. Journal of the American Academy of Dermatology 44:2, pages 253-260.
Crossref
Uwe Wollina, Tim Graefe & Kerstin Karte. (2000) Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin. Journal of the American Academy of Dermatology 42:1, pages 40-46.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.